BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:13 PM
 | 
Jul 10, 2009
 |  BC Extra  |  Company News

Endo gets U.S. rights to Bioniche's Urocidin

Bioniche Life Sciences Inc. (TSX:BNC) granted Endo Pharmaceuticals Inc. (NASDAQ:ENDP) exclusive U.S. rights to Urocidin, a mycobacterial cell wall-DNA...

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >